According to our new research study on "Canada enteral nutrition market Size and Forecast to 2031 - Country Analysis - by Product, Formula Type, Route of Administration, and End User," the market is expected to grow from CA$ 514.33 million in 2022 to CA$ 817.11 million by 2031; it is estimated to record a CAGR of 6.0% during 2023-2031.

Enteral nutrition refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver nutrition and calories to fulfill an individual's caloric requirements. It can include a normal oral diet, liquid supplements, or delivery using a tube (tube feeding). It is provided to patients whose energy and nutritional needs cannot be met by a regular food intake. The Canada enteral nutrition market report emphasizes the key factors driving the market and depicts the developments of prominent players.

The Canadian Mental Health Association celebrates Eating Disorder Awareness Week by wearing purple on February 1 Every year. Cachexia, anorexia, and eating disorders are related in a way that highlights the complex interactions between physiological, psychological, and metabolic aspects. Cachexia is a multifunctional disease that causes extreme weight loss, skeletal muscle and adipose tissue loss, metabolic regulation imbalance, and food intake reduction. In people with underlying medical disorders, anorexia (a chronic lack of appetite or reduced food intake) may play a role in the onset or aggravation of cachexia. Reduced calorie intake in anorexic patients further hampers their metabolic capacity to preserve muscle mass, store vital nutrients, and attain general metabolic equilibrium, subsequently accelerating the development of cachexia. According to the National Initiative for Eating Disorders, as of 2023, anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), avoidance restrictive food intake disorder (ARFID), and otherwise specified feeding and eating disorder (OSFED) affect approximately 1 million Canadians who have been diagnosed with an eating disorder. Additionally, according to the Canadian Community Health Survey, 1.8% of women aged 65 or more and 2.6% of women from the age group of 50-64 reported having an eating disorder. Thus, with the burgeoning incidence of cachexia, anorexia, and eating disorders-collaborative efforts, awareness initiatives, and implementation of tailored interventions that target both the physical and psychological aspects of the abovementioned conditions support the Canada enteral nutrition market growth.

Nestle SA, Abbott Laboratories, Fresenius Medical Care AG & Co KgaA, Koninklijke DSM NV, and B Barun SE are among the leading companies operating in the India veterinary diagnostic test kits market.

Based on disease indication, the orthopedic disorders segment held the largest Canada enteral nutrition market share in 2023. The Cardiovascular disorders segment is anticipated to register the highest CAGR during 2023-2031.

Based on formula type, the companion animals segment held a larger market share in 2023. The standard formulas segment is anticipated to register a higher CAGR from 2023 to 2031 and the same segment held a larger Canada enteral nutrition market share.

Based on the route of administration, the oral segment held a larger share of the Canada enteral nutrition market in 2023, and it is anticipated to register a higher CAGR during 2023-2031.

In terms of end user, the long-term care facilities segment is anticipated to account for a significant market share during 2023-2031.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com